Cancer Vaccines: Early Beginnings

  • | May 25 2017 |

At the ACGT anniversary gala in April, Robert Vonderheide, MD, DPhil, the Hanna Wise Professor in Cancer Research and newly appointed Director of the Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, briefed the audience on the progress of his research using immunotherapy for pancreatic cancer and other solid tumors. ACGT […]

Read More

Philanthropists Make Miracles Happen

  • | Jan 27 2017 |

You might be surprised to learn that only one percent of grant funding from the National Institutes of Health [NIH] is awarded to young researchers. In contrast, ACGT uses half of its funding for clinical trials and half of its funding goes to young scientists exploring revolutionary approaches to cancer treatment. We are second to […]

Read More

OV Therapy – The Next Frontier is Closer Than You Think

  • | Sep 21 2016 |

This fourth in our blog series on the progress of cell and gene therapy for cancer focuses on a treatment that has made huge strides in recent years: Viral Therapy. What is Viral Therapy? Using viruses to target disease is a science first contemplated over a hundred years ago, but was not possible until the […]

Read More

Celebrate Breakthrough Cancer Research

  • | Dec 24 2015 |

As we celebrate this wonderful season of giving, we want to thank all of our donors for helping support ACGT’s breakthrough research. And we want to thank our researchers and their patients who are continually moving cell and gene therapies for cancer to the forefront of innovation in the treatment of this deadly disease. 2015 […]

Read More

Patient in China Free of Leukemia After CAR T cell Therapy,

  • | Dec 17 2015 |

In China, a patient whose life was close to its end was completely cured of leukemia by stimulating the immune system using CAR T-cell therapy. In the first study of its type, all cancer cells quickly disappeared. Immune-mediated treatment, pioneered in this country by ACGT scientists Dr. Carl June, University of Pennsylvania, and Dr. Michel […]

Read More

An Amazing, Unprecedented Documentary on Cancer

  • | Mar 30 2015 |

At Alliance for Cancer Gene Therapy (ACGT), we strive to revolutionize how we treat and understand cancer. The scientists we fund, and the donors who share their resources, envision a world where a cancer diagnosis doesn’t signal hopelessness. They imagine a world where cancer is a manageable disease — one that doesn’t require surgery, radiation […]

Read More

Immunotherapy Receives a $100 Million Boost

  • | Feb 16 2015 |

The University of Texas’ MD Anderson Cancer Center — one of the most esteemed cancer laboratories and centers in the world — is in the vanguard of advancing and unlocking the amazing abilities of immunotherapy. And recently, MD Anderson Cancer Center’s work earned major plaudits and support: The hospital was awarded $100 million for its groundbreaking research. […]

Read More

ACGT Advisor Makes Immunotherapy More Accessible

  • | Feb 02 2015 |

At Alliance for Cancer Gene Therapy (ACGT), our vision is to transform cancer from a harrowing disease into a manageable diagnosis. We believe — along with the brilliant scientists who provide research, treatment and scientific counsel — that this can be unlocked through immunotherapy and cell and gene therapies. And so we are overjoyed that recently, immunotherapy […]

Read More

ACGT Grantees Achieve Milestones in Lymphyblastic Leukemia Research and Treatment

  • | Jan 15 2015 |

Lymphyblastic leukemia is a destructive, painful blood cancer that progresses quickly and can be fatal within months if left untreated. And while treatments such as chemotherapy are currently commonly used, many patients suffer relapse, lowering the disease’s overall cure rate to between 30 and 40 percent. But the genetic modification of T-lymphocytes is now emerging […]

Read More